Issues Requiring Pharmacist Intervention
Issues that require pharmacist intervention: drug utilization review (DUR), adverse drug event (ADE), OTC recommendation, therapeutic substitution, misuse, adherence, and more.
Issues that require pharmacist intervention represent 4.0% of the PTCE. This topic tests the line between what a pharmacy technician may handle and what must be escalated to the pharmacist — the clinical judgment calls. Any question that involves interpreting clinical significance, counseling, or changing therapy belongs to the pharmacist. Your job as a technician is to recognize the trigger and route it correctly, not to make the clinical decision yourself.
Drug Utilization Review (DUR)
A DUR is a systematic review of a patient's medication use to identify problems such as therapeutic duplication, drug-drug or drug-disease interactions, incorrect dose or duration, allergies, and misuse. DUR occurs in three timeframes: prospective (before the drug is dispensed), concurrent (during ongoing therapy), and retrospective (after dispensing, reviewing past claims). A technician may enter the prescription that triggers a DUR alert, but interpreting and resolving the alert is the pharmacist's responsibility.
Prospective = before dispensing, concurrent = during therapy, retrospective = after the fact.
Adverse Drug Events and Clinical Judgment
An adverse drug event (ADE) — any harm resulting from medication use — must be evaluated by the pharmacist, who decides whether therapy should change and whether the event needs to be reported. The same escalation applies to a therapeutic substitution (switching to a therapeutically equivalent but chemically different drug per formulary or protocol), which requires a pharmacist's clinical authorization, unlike a routine generic substitution a technician can process. Suspected misuse, abuse, or diversion — such as early controlled-substance refills or pattern red flags — is also a mandatory pharmacist referral.
Generic substitution is routine; therapeutic substitution changes the actual drug and needs pharmacist authorization.
Counseling, OTC Recommendations, and Adherence
Under OBRA '90, the pharmacist must offer to counsel patients on new prescriptions, and any patient question requiring clinical advice — an OTC product recommendation, whether two drugs can be taken together, what a side effect means — must go to the pharmacist. Technicians cannot counsel or recommend drug therapy. Adherence issues (a patient not refilling on time, skipping doses, or misunderstanding directions) are flagged by the technician but addressed clinically by the pharmacist.
Must-Know for the Exam
- ✓DUR checks for duplication, interactions, wrong dose/duration, allergies, and misuse
- ✓DUR timeframes: prospective (before dispensing), concurrent (during therapy), retrospective (after dispensing)
- ✓An adverse drug event (ADE) is any harm from medication use and must be evaluated by the pharmacist
- ✓Therapeutic substitution swaps to a different drug and requires pharmacist authorization; generic substitution does not
- ✓OBRA ’90 requires the pharmacist to offer counseling on new prescriptions
- ✓Technicians cannot counsel patients or recommend OTC/prescription therapy
- ✓Suspected misuse, abuse, or diversion is a mandatory pharmacist referral
- ✓Adherence problems are flagged by the technician but resolved clinically by the pharmacist
Common Exam Mistakes
- ✗Believing a technician can recommend an OTC product to a patient
- ✗Confusing therapeutic substitution (different drug, needs pharmacist) with generic substitution (same drug, routine)
- ✗Mixing up the DUR timeframes — retrospective is after dispensing, not before
- ✗Thinking a technician can override or clear a DUR alert without the pharmacist
- ✗Treating a patient clinical question as something the technician may answer
Quiz yourself on Issues Requiring Pharmacist Intervention
Test what you just read — instant feedback on every question.
Start Issues Requiring Pharmacist Intervention Practice Quiz →Key Concepts — Part 1
1. What is a Drug Utilization Review (DUR), and at what stage does it typically occur in the dispensing process?
A screening (often automated, then evaluated by the pharmacist) for issues like interactions, duplications, and allergies, typically performed during order entry before dispensing
A DUR screens each prescription (often through automated system checks) for problems such as drug interactions, therapeutic duplication, or allergy conflicts, and any flags require pharmacist evaluation before the prescription is verified. It has nothing to do with revenue audits, satisfaction surveys, or inventory counts.
2. During data entry, the pharmacy system flags a moderate drug interaction between a new prescription and a medication the patient is already taking. What should the technician do?
Leave the alert for the pharmacist to review and resolve, since interaction significance requires clinical judgment
Interaction alerts require clinical judgment about severity and relevance to the specific patient, which is outside a technician's scope -- the alert should be routed to the pharmacist for evaluation. Technicians should not override, decide for the patient, or alter the medication profile to make an alert disappear.
3. A patient asks a technician, 'Which allergy medicine is stronger, this one or that one?' What is the appropriate response?
Refer the question to the pharmacist, since recommending or comparing OTC products is a clinical judgment outside the technician's scope
OTC product recommendations and comparisons involve clinical judgment about the patient's health history and needs, which falls within the pharmacist's scope, not the technician's. Personal opinions, price-based guesses, or telling the patient to choose randomly are not appropriate substitutes for pharmacist consultation.
4. A prescriber's office calls asking the pharmacy to switch a patient's prescription to a different drug within the same therapeutic class due to a formulary issue. Who should evaluate and authorize this therapeutic substitution?
The pharmacist, since deciding on a clinically appropriate substitute requires pharmacological judgment
Therapeutic substitution involves choosing a clinically comparable alternative, which requires pharmacological knowledge beyond the technician's scope -- this is pharmacist territory, sometimes under a pre-approved protocol. It is not routine data entry, and while the patient's consent may be needed, they are not the one making the clinical substitution decision.
5. A patient tells a technician they developed a rash a few days after starting a new antibiotic. What should the technician do?
Notify the pharmacist promptly so they can assess the possible adverse drug event
A possible adverse drug event needs pharmacist assessment -- the technician should relay the information promptly rather than advise the patient clinically in either direction (stop or continue) or simply let it go undocumented in the system. This ensures the reaction is properly evaluated and reported if needed.
6. A technician notices in the fill history that a patient has requested early refills of a controlled substance several months in a row, each time 8-10 days before the prescription should have run out. What is the appropriate action?
Flag the pattern for pharmacist review, since it may indicate misuse, diversion, or another issue requiring clinical judgment
A repeated pattern of early refill requests for a controlled substance is a recognized red flag for possible misuse or diversion that requires pharmacist evaluation (and possibly prescriber contact), not a technician's unilateral denial or approval. Contacting an employer would be inappropriate and a privacy violation.
7. A technician notices that a patient hasn't picked up a maintenance medication refill in over two months, based on the fill history. What is the appropriate next step?
Flag it for the pharmacist, who can assess adherence concerns and determine if patient counseling is needed
A significant gap in refill pickups can signal a non-adherence issue that may need clinical follow-up (e.g., side effects, cost barriers, confusion about the regimen), which is best addressed through pharmacist-led counseling. Ignoring it, canceling future refills, or shipping medication without contact do not address the underlying concern.
8. During order entry, the system flags that a new prescription conflicts with a documented allergy on the patient's profile. What should the technician do?
Halt processing and route the flag to the pharmacist for resolution before the prescription is filled
An allergy conflict requires the pharmacist to assess the clinical significance and, if needed, contact the prescriber -- a technician should not fill through the flag, alter the patient's allergy record, or substitute a coworker's opinion for pharmacist judgment.
9. A pregnant patient asks a technician whether a particular over-the-counter cold medication is safe to take during pregnancy. What should the technician do?
Refer the question to the pharmacist, who can evaluate the safety of the specific product for this patient
Questions about medication safety in pregnancy require clinical evaluation specific to the drug and trimester, which is the pharmacist's role -- a technician giving general or absolute answers (or directing the patient to unreliable sources) is outside their scope and could be misleading or unsafe.
10. A technician processing a new prescription notices the patient already has an active fill for a different drug in the same therapeutic class from another prescriber. What should the technician do?
Flag the therapeutic duplication for the pharmacist to evaluate, since it may be intentional, an error, or a sign of uncoordinated care
Therapeutic duplication from different prescribers can be legitimate, accidental, or a sign of uncoordinated care, and only the pharmacist can determine the appropriate next step (which may include contacting a prescriber). A technician should not silently fill both, discard either prescription, or leave the decision entirely to the patient.
Key Concepts — Part 2
1. An insurance claim rejects and requires a clinical override code to process. Who determines the clinically appropriate override justification?
The pharmacist, since selecting a clinically accurate override requires assessing the patient's situation
While technicians often handle the administrative submission of insurance overrides, choosing which clinical justification actually applies to the patient's situation requires pharmacist judgment -- picking whatever code processes fastest without clinical basis would be inappropriate and potentially inaccurate.
2. A technician sees a note in the patient's profile indicating reduced kidney function, and a new prescription is written at the standard adult dose for a renally-cleared medication. What should the technician do?
Flag it for pharmacist review to determine whether a dose adjustment is clinically needed
Determining whether a renally-cleared drug needs dose adjustment for a specific patient's kidney function is a clinical decision for the pharmacist, not something a technician should calculate or assume the prescriber already handled. Asking the patient for a clinical opinion is not an appropriate substitute for pharmacist review.
3. What is the key distinction between an adverse drug event (ADE) and a medication error?
An ADE is any harm resulting from medication use (which may occur even without any mistake, such as a known side effect), while a medication error is a preventable mistake in the medication-use process that may or may not cause harm
An ADE refers to harm from a medication, which can happen even with correct use (e.g., a recognized side effect), while a medication error is specifically a preventable mistake somewhere in the process -- the two overlap but are not identical concepts. Medication errors don't always cause harm (some are near misses), and ADEs are not limited to vaccines.
4. A patient asks a technician whether it's safe to take an herbal supplement, such as St. John's Wort, alongside their prescription antidepressant. What should the technician do?
Refer the question to the pharmacist, since supplement-drug interactions require clinical evaluation
St. John's Wort has clinically significant interactions with many prescription drugs, including antidepressants; assessing this requires pharmacist-level knowledge, not an assumption that 'natural' means safe. Advising a patient to stop a prescription medication is well outside a technician's authority.
5. A patient asks a technician if it is okay to split their extended-release tablet in half to make it easier to swallow. What should the technician do?
Refer the question to the pharmacist, since splitting some formulations (like extended-release) can affect how the drug is released and absorbed
Splitting an extended-release tablet can destroy its controlled-release mechanism, potentially causing a rapid, unsafe release of the full dose -- whether a tablet can be safely split is a clinical question for the pharmacist, not a blanket 'yes.' Suggesting crushing would be even riskier and is not the technician's call to make.
6. A technician notices signs that a written prescription may have been altered (e.g., different ink color on the quantity field). What should the technician do?
Notify the pharmacist immediately and do not process the prescription until it is reviewed
A suspected forged or altered prescription is a serious issue requiring pharmacist (and potentially prescriber or law enforcement) involvement before any action is taken -- technicians should not fill it, confront the patient themselves, or make unilateral corrections.
7. Under a pharmacy's P&T-committee-approved therapeutic interchange protocol, who has the authority to actually make a substitution for a specific patient's prescription?
The pharmacist, who applies clinical judgment to confirm the protocol is appropriate for that specific patient before substituting
Even under a pre-approved interchange protocol, the pharmacist must apply judgment to confirm the substitution is appropriate for the individual patient (e.g., no contraindications) before it happens -- a technician cannot make that determination independently, and it isn't a decision for non-pharmacy staff.
8. A patient mentions to a technician that they've missed several doses of their blood pressure medication over the past month. What is the appropriate technician response?
Inform the pharmacist so they can assess adherence and provide appropriate counseling
Missed doses of a chronic medication may reflect side effects, cost issues, or misunderstanding of the regimen, all of which benefit from pharmacist counseling -- a technician should not give clinical advice (like doubling doses) or dismiss the concern, and should not process refills without appropriate pharmacist awareness of the adherence issue.
9. A new prescription for a controlled substance is written for a quantity significantly higher than what the patient has historically received for the same medication. What should the technician do?
Flag it for pharmacist review, since a significant unexplained increase could reflect a legitimate change, a prescribing error, or a misuse concern
A significant, unexplained increase in a controlled substance quantity is exactly the kind of change that needs pharmacist evaluation -- it may be legitimate or may signal an error or misuse concern, and only the pharmacist has the scope to investigate, often by contacting the prescriber. Technicians should neither fill it blindly nor take unilateral action to alter or refuse it.
10. Which of the following tasks requires pharmacist judgment rather than falling within a pharmacy technician's typical scope of practice?
Determining whether a prescribed dose is clinically appropriate given the patient's other medications and conditions
Assessing whether a dose is clinically appropriate for a specific patient requires pharmacological and clinical judgment, which is reserved for the pharmacist. Data entry, counting/packaging non-hazardous medications, and restocking are standard technician tasks that do not involve clinical decision-making.
Ready to test your knowledge?
Practice questions with instant feedback and explanations.
Take a PTCB Practice Test →